A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Clinical trial NCT05504837 · RECRUITING

Trial details

NCT number: NCT05504837
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2023-06-30
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.